European Union -
English -
EMA (European Medicines Agency)
adtralza
leo pharma a/s - tralokinumab - dermatitis, atopic - other dermatological preparations - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alzain 25mg capsules
dr reddy's laboratories (uk) ltd - pregabalin - oral capsule - 25mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alzain 50mg capsules
dr reddy's laboratories (uk) ltd - pregabalin - oral capsule - 50mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alzain 75mg capsules
dr reddy's laboratories (uk) ltd - pregabalin - oral capsule - 75mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alzain 100mg capsules
dr reddy's laboratories (uk) ltd - pregabalin - oral capsule - 100mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alzain 150mg capsules
dr reddy's laboratories (uk) ltd - pregabalin - oral capsule - 150mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alzain 200mg capsules
dr reddy's laboratories (uk) ltd - pregabalin - oral capsule - 200mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alzain 225mg capsules
dr reddy's laboratories (uk) ltd - pregabalin - oral capsule - 225mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alzain 300mg capsules
dr reddy's laboratories (uk) ltd - pregabalin - oral capsule - 300mg
Canada -
English -
Health Canada
adtralza solution
leo pharma inc - tralokinumab - solution - 150mg - tralokinumab 150mg - misc. skin and mucous membrane agents